Estel Plana, MSc

Director Biostatistician
Pharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain, Spain

Poster(s):

• (A-338) Evaluating the Diagnostic Accuracy of Adverse Events of Special Interest Following Janssen COVID-19 Vaccine (JCOVDEN) Using the VAC4EU Validation Pipeline
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (C-152) Impact of design choices that deviate from a target trial emulation. An application to the estimation of the effect of anticholinergic properties of antidepressants on the incidence of dementia
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (A-280) Like father, like child: feasibility of linking father and child in CPRD GOLD
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (SLC-053) Risk of Venous Thrombosis With Thrombocytopenia Syndrome After Vaccination With AZD1222: A European VAC4EU Post-Authorisation Safety Study
  Tuesday, August 26, 2025

  12:15 PM - 1:15 PM ET